查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571462

避孕藥和避孕器市場規模、佔有率、趨勢分析報告：按產品、地區、細分市場預測，2024-2030 年

Contraceptive Drugs And Devices Market Size, Share & Trends Analysis Report By Product (Contraceptive Drugs (Contraceptive Pills, Patch, Injectable), Contraceptive Devices), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

避孕藥和避孕器市場規模和趨勢：

2023年，全球避孕藥和避孕器市場規模將達296億美元，預計2024年至2030年複合年成長率為5.9%。

市場成長是由性行為感染傳染病（STD）和意外懷孕的增加所推動的。政府為傳播避孕意識而採取的越來越多的措施導致了市場的成長。此外，政府有關人口控制的政策也預計將有助於市場成長。

政府正在投入大量資金，提高人們對性傳染病和墮胎以及如何透過避孕藥具和避孕器的幫助來避免這些疾病的認知。政府也正在宣傳計劃生育意識，最終將有助於政府控制人口。此外，由於對安全有效的避孕方法的需求不斷增加，各大製藥公司正在大力投資研發以改善避孕藥和避孕器。因此，這些因素都促進了這個市場的成長。

人口成長，特別是中低收入地區的人口成長，導致避孕藥具的廣泛使用並推動市場成長。人們對性健康和計劃生育的認知不斷提高，對有效避孕方法的需求也隨之增加，以幫助應對意外懷孕。此外，都市化和生活方式的改變（例如為了職業目標而推遲懷孕）正在推動市場成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章避孕藥和避孕器市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 避孕藥及裝置市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 避孕藥與避孕器市場：產品估算與趨勢分析

  • 細分儀表板
  • 避孕藥和避孕器市場：2023 年和 2030 年按產品分類的波動分析
  • 避孕藥
  • 避孕器

第5章避孕藥和避孕器市場：區域估計和趨勢分析

  • 2023 年和 2030 年按地區分類的避孕藥和避孕器具市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Abbvie, Inc.
    • Afaxys, Inc.
    • Agile Therapeutics
    • Bayer AG
    • China Resources（Holdings）Co., Ltd.
    • Church &Dwight Co., Inc.
    • Cupid Limited
    • Helm AG
    • Johnson &Johnson Services, Inc.
    • Organon Group of Companies
    • Pfizer Inc.
    • Veru, Inc.
    • Viatris Inc.
簡介目錄
Product Code: 978-1-68038-032-3

Contraceptive Drugs And Devices Market Size & Trends:

The global contraceptive drugs and devices market size was valued at USD 29.6 billion in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030. The market growth can be attributed to an increase in the number of sexually transmitted diseases (STDs) and unintended pregnancies. A growing number of initiatives taken by the governments to spread awareness about contraception have resulted in market growth. Furthermore, government policies on controlling the population are expected to contribute to market growth.

The government is investing heavily in spreading awareness of STDs and abortion and how they are avoided with the help of contraceptive drugs or devices. The government is also spreading awareness about family planning, which will ultimately help the government in population management. Furthermore, key pharmaceutical companies are investing heavily in research and development to upgrade contraceptive drugs and devices as there is an increased demand for safe and effective contraceptive measures. Therefore, these factors have contributed to the growth of this market.

The increase in the population, especially in the middle and low-income regions, has resulted in market growth, as there is a rise in the popularity of contraceptive measures. With the rise in awareness regarding sexual health and family planning, there is an increased demand for effective contraceptive measures that can help in dealing with unwanted pregnancies. Furthermore, urbanization and changes in lifestyle, such as delaying pregnancy due to professional goals, are adding to the growth of the market.

Global Contraceptive Drugs And Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global contraceptive drugs and devices market report based on product and region.

  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Contraceptive Drugs
    • Contraceptive Pills
    • Patch
    • Injectable
  • Contraceptive Devices
    • Condoms
    • Male Condoms
    • Female Condoms
    • Subdermal Implants
    • Intrauterine Devices (IUDs)
    • Copper IUDs
    • Hormonal IUDs
  • Vaginal Ring
  • Diaphragm
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Contraceptive Drugs and Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Contraceptive Drugs and Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Contraceptive Drugs and Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Contraceptive Drugs and Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Contraceptive Drugs
    • 4.3.1. Contraceptive Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Contraceptive Pills
      • 4.3.2.1. Contraceptive Pills Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Patch
      • 4.3.3.1. Patch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Injectable
      • 4.3.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Contraceptive Devices
    • 4.4.1. Contraceptive Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Condom
      • 4.4.2.1. Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.2. Male Condom
        • 4.4.2.2.1. Male Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.2.3. Female Condom
        • 4.4.2.3.1. Female Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Subdermal Implants
      • 4.4.3.1. Subdermal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Intrauterine Devices (IUDs)
      • 4.4.4.1. Intrauterine Devices (IUDs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.2. Copper IUDs
        • 4.4.4.2.1. Copper IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.4.3. Hormonal IUDs
        • 4.4.4.3.1. Hormonal IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Vaginal Ring
      • 4.4.5.1. Vaginal Ring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Diaphragm
      • 4.4.6.1. Diaphragm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Contraceptive Drugs and Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Contraceptive Drugs and Devices Market Share, By Region, 2023 & 2030 (USD Billion)
  • 5.2. North America
    • 5.2.1. North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.2.4. Mexico
      • 5.2.4.1. Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. UK
      • 5.3.2.1. UK Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Italy
      • 5.3.5.1. Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Spain
      • 5.3.6.1. Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Denmark
      • 5.3.7.1. Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.8. Sweden
      • 5.3.8.1. Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.9. Norway
      • 5.3.9.1. Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. China
      • 5.4.3.1. China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. India
      • 5.4.4.1. India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Australia
      • 5.4.5.1. Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. South Korea
      • 5.4.6.1. South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Thailand
      • 5.4.7.1. Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Argentina
      • 5.5.3.1. Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Middle East and Africa
    • 5.6.1. Middle East and Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Heat Map Analysis
  • 6.4. Company Profiles
    • 6.4.1. Abbvie, Inc.
      • 6.4.1.1. Participant's Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Recent Developments/ Strategic Initiatives
    • 6.4.2. Afaxys, Inc.
      • 6.4.2.1. Participant's Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Recent Developments/ Strategic Initiatives
    • 6.4.3. Agile Therapeutics
      • 6.4.3.1. Participant's Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Recent Developments/ Strategic Initiatives
    • 6.4.4. Bayer AG
      • 6.4.4.1. Participant's Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Recent Developments/ Strategic Initiatives
    • 6.4.5. China Resources (Holdings) Co., Ltd.
      • 6.4.5.1. Participant's Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Recent Developments/ Strategic Initiatives
    • 6.4.6. Church & Dwight Co., Inc.
      • 6.4.6.1. Participant's Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Recent Developments/ Strategic Initiatives
    • 6.4.7. Cupid Limited
      • 6.4.7.1. Participant's Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Recent Developments/ Strategic Initiatives
    • 6.4.8. Helm AG
      • 6.4.8.1. Participant's Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Recent Developments/ Strategic Initiatives
    • 6.4.9. Johnson & Johnson Services, Inc.
      • 6.4.9.1. Participant's Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Recent Developments/ Strategic Initiatives
    • 6.4.10. Organon Group of Companies
      • 6.4.10.1. Participant's Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Recent Developments/ Strategic Initiatives
    • 6.4.11. Pfizer Inc.
      • 6.4.11.1. Participant's Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Recent Developments/ Strategic Initiatives
    • 6.4.12. Veru, Inc.
      • 6.4.12.1. Participant's Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Recent Developments/ Strategic Initiatives
    • 6.4.13. Viatris Inc.
      • 6.4.13.1. Participant's Overview
      • 6.4.13.2. Financial Performance
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Recent Developments/ Strategic Initiatives